Cepheid

"I think the public could learn more about antimicrobial resistance and superbugs, and their impact on public health" The Fleming Initiative asked members of the public for their thoughts on antimicrobial resistance and 'superbugs' for #WorldAMRAwarenessWeek Our partner Cepheid is shining the spotlight on the rising rates of Carbapenemase-producing Enterobacterales (CPE) in the UK. These “superbugs” pose one of the greatest threats to public health and the NHS, but together we can make a difference. Watch the video below and visit https://lnkd.in/e3fXWePy to learn more! #WAAW #AMR #antimicrobialresistance

Our resident expert, Scott Sugden, Ph.D., Director of Medical Affairs at Cepheid Canada authored this piece on the emerging threat of invasive Group A Strep. #StrepA #Respiratory What do you need to know?? ? ?? An alarming increase in cases of invasive Group A Streptococcus (iGAS) infection worldwide has reignited concerns over the pathogenic potential of Group A Streptococcus (GAS) and its capacity to cause severe diseases.??? ?? The U.S. Centers for Disease Control and Prevention (CDC) reported that rates of serious GAS disease have been increasing since 2014, but the number of serious GAS infections reached a 20-year high in 2023. ?? Advances in antibiotics and public health measures have generally kept GAS infections in check, but the recent spike in iGAS cases signals a critical need for renewed vigilance.? Read the full story on Cepheid’s Insight Hub >>> https://lnkd.in/gtdiszvh

“Superbugs” like carbapenemase-producing Enterobacterales (CPE) can spread rapidly and cause outbreaks. Their limited treatment options and strong association with healthcare settings means they can be particularly disruptive and costly, posing a significant threat to the NHS as it continues to tackle the elective backlog.* UKHSA has published a framework of actions to contain CPE which in particular emphasises the need for each health provider to implement targeted admission screening based on regional prevalence to help prevent transmission and protect patients.* This #WorldAMRWeek, download our comprehensive infographic and join the fight to protect public health: https://ow.ly/qSaQ50U8jw9 This briefing has been developed by Cepheid and supported by the Fleming Initiative #AMR #Superbugs #CPEAwareness #UKHealth

Simplify. Test. Act. At Cepheid, our goal is advancing diagnostic solutions to improve patient outcomes. Our advanced technology + simple workflow = accurate, actionable results. It's as easy as 1, 2, 3! This World Hepatitis Testing Week, join us in choosing A Better Way for patients. Together with the World Hepatitis Alliance, we're raising awareness and making a difference. #HepTestWeek #HepCantWait #DiagnosticInnovation #HealthcareTechnology #ABetterWay Remember: Accurate, actionable testing is a crucial first step in eliminating hepatitis. Start today. Connect with a Cepheid associate today us this link: https://lnkd.in/gsbj_P69 IVD. In Vitro Diagnostic Medical Device. May not be available in all countries?

Carbapenemase-producing Enterobacterales (CPE) “superbugs” are on the rise in the UK. In fact, the rate of CPE infections has increased in recent years from 0.91 per 100,000 people in Q1 2021, to 3.5 per 100,00 people in Q2 2024, a nearly three-fold increase since mandatory reporting came into effect.* Most worryingly, CPE does not affect us equally, with the most deprived communities being hit the hardest, meaning targeted action is needed now more than ever. This #WorldAMRWeek, download our comprehensive infographic and join the fight to protect public health: https://ow.ly/fthv50U8jgv This briefing has been developed by Cepheid and supported by the Fleming Initiative. #AMR #Superbugs #CPEAwareness #UKHealth

It's World Hepatitis Testing Week! Did you know that millions of people worldwide are living with hepatitis without even knowing it? This #HepTestWeek, let's change that together. At Cepheid, we're proud to partner with the World Hepatitis Alliance to raise awareness about the importance of hepatitis testing. Our innovative diagnostic solutions are bringing testing to patients when and where they need it most. We kicked off the week with an insightful panel discussion at #TLM24, exploring the latest advancements in hepatitis diagnostics. #HepTestWeek #DiagnosticInnovation #ABetterWay Let's work towards eliminating hepatitis. #HealthcareTechnology #CepheidLive #HCV #HepCantWait Learn more about our innovative diagnostics solutions. Visit cepheid.com

Take our poll on LinkedIn Live event from yesterday. Comment below to share what specific aspects of these topics interest you most. Your input is valuable in shaping our upcoming events! #DiagnosticInnovation #HealthcareTechnology #ABetterWay #CepheidLive #LinkedInPoll

In the world of antibiotic resistance, not all bugs are equal – some are “super.” Carbapenemase-producing Enterobacterales (CPE) are a class of bacteria which produce carbapenemase enzymes. These “superbugs” are resistant to many antibiotics of last resort. Resistance to these antibiotics risks a world where we have no treatment options remaining. This #WorldAMRWeek, download our comprehensive infographic and join the fight to protect public health: https://ow.ly/nORB50U8iCM This briefing has been developed by Cepheid and supported by the Fleming Initiative #AMR #Superbugs #CPEAwareness #UKHealth

Join us at Booth #1032 at AMP. Don’t miss out on live demos, expert insights, and product information! See you there! #AMP #HealthcareInnovation #MolecularDiagnostics https://amp24expo.amp.org/

?? Join Cepheid's First Ever LinkedIn LIVE Panel Discussion at AASLD, The Liver Meeting! ?? Distinguished panelists will discuss revolutionizing HCV elimination programs with point-of-care HCV RNA testing. ?? Add the event to your calendar today!